Head of Biologics
About the company
Ailomics Therapeutics is a pharmaceutical R&D startup with a pioneering computational and experimental platform to discover novel targets and develop efficacious therapeutics for the diseases of significant unmet medical needs. Ailomics Therapeutics leverages patients-derived omics data and AI-augmented bioinformatics analytics to deeply understand disease biology and identify the targets that drive disease progressions. Learning from human disease biology, Ailomics Therapeutics develops high-translatability disease models to screen for and optimize functional molecules for therapeutic interventions. The human disease biology insights also enable Ailomics Therapeutics to discover high-precision biomarkers for patient stratification in clinical trials.
Position Overview
The Head of Biologics will play a crucial role in the discovery and development of biologics for first-in-class targets of immunology diseases. This role leads the Biologics team to generate antigens and antibodies and is the key contact person for external partners on biologics R&D, patent filings and collaborations. The ideal candidate has a strong background in antibody drug R&D in an industry setting, high capability in problem solving, a keen eye for details, and excellent communication and leadership skills.
Responsibilities
Lead and develop the Biologics team with a strategy and capabilities aligned with company mission and strategy.
Participate in novel target proposing, evaluation and validation and provide a tailored biological modality solution (mostly antibody of a suitable format) for any given target.
Lead the team to generate antigens of suitable formats for immunization, antibody screening, and functional studies.
Lead the team to discover biologics of suitable formats for first-in-class targets, for which reference biologics may not exist.
Lead to humanize biologics and to optimize the functions, developability, PK and toxicity of biologics.
Select and work with CROs and CDMOs for the full value chain of biologics R&D.
Streamline biologics R&D for high efficiency by optimal integration of internal and external capabilities.
Represent Biologics function in external communications and collaborations.
Co-lead patent filings on biological assets.
Co-lead lab digitalization including compound registration, inventory management and laboratory condition monitoring, etc.
Have the opportunities to lead technology development in biologics R&D.
Qualifications
Ph.D. in Molecular Biology, Biotechnology, Immunology or a relevant field. Oversea experience is a plus.
5-10 years of antibody drug R&D experience in the industry.
First authorship on peer-reviewed publications and co-inventorship on antibody patents or patent applications are mandatory.
Clear understanding of the full value chain of antibody drug R&D.
Experience of leading antibody projects to PCC or IND is a big plus.
Demonstrated capability of antigen generation, antibody discovery and characterization for novel or challenging targets.
Experience of managing CRO or CDMO studies is a big plus.
Experience of utilizing computational approaches is a big plus.
Demonstrated capability of solving challenging strategic or technical problems with innovative solutions.
Passion for biologics drug R&D on first-in-class targets.
Strong leadership, teamwork, and communication skills.
Highly organized with a keen eye on details.
Proficient in verbal and written English & Mandarin communications.
Location:
ATLATL Innovation Cluster (atlatl.cn), Pharma Valley, Zhangjiang Hi-Tech Park, Shanghai, China
Type of Position:
Leader
HR Contact:
hr@ailomics.com
Website:
www.ailomics.com